MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0044654
Cytocare Technologies Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹42.9 Cr
▲ 60% YoY
Net profit · FY 2025
₹3.35 Cr
Net margin 7.8%
EBITDA · FY 2025
₹4.84 Cr
EBITDA margin 11.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹32.56 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Cytocare Technologies Private Limited
Data last updated:
Cytocare Technologies Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG2012PTC083748. Its GSTIN is 36AAFCC0254Q1ZF (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nedun Chezhian Murugaiyan and Nedunchezhian Vijayalakshmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 – 5 – 1 – G1 Pvn Colony Mirjalguda Malkajgiri, Hyderabad, Telangana, India – 500047.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.9 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹3.35 Cr (net margin 7.8%) and EBITDA of ₹4.84 Cr (EBITDA margin 11.3%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 48% over five years.
The company is associated with 1 brand: Cytocare Technologies. As per MCA filings, the company has open charges of ₹32.56 Lakh on record.
Cytocare Technologies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0044654). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cytocaretech.com.
Company Details of Cytocare Technologies Private Limited
CIN U72200TG2012PTC083748
Registration Number 083748
Incorporation Date 22 October 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0044654
CIN History of Cytocare Technologies Private Limited
Cytocare Technologies has one previous CIN (Corporate Identification Number): U72200AP2012PTC083748. The current CIN is U72200TG2012PTC083748, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200TG2012PTC083748 | Current |
| U72200AP2012PTC083748 | Previous |
Recognitions & Rankings of Cytocare Technologies
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address10 – 5 – 1 – G1 Pvn Colony Mirjalguda Malkajgiri, Hyderabad, Telangana, India – 500047
- IndustryChemicals and Materials, Industrial Chemicals
Comprehensive company report
Cytocare Technologies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Cytocare Technologies Private Limited
Cytocare Technologies operates one associated brand: Cytocare Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive mammalian cell line development and manufacturing services. | cytocaretech.com |
Business Activity of Cytocare Technologies Private Limited
The main business activity of Cytocare Technologies is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cytocare Technologies Private Limited FY 2025 filings available
Cytocare Technologies Private Limited reported revenue of ₹42.9 Cr (up 60% YoY) for FY 2025.
Revenue · FY 2025
₹42.9 Cr ▲ 60%
Net profit · FY 2025
₹3.35 Cr margin 7.8%
EBITDA · FY 2025
₹4.84 Cr margin 11.3%
Compounded Annual Growth Rate (CAGR) of Cytocare Technologies Private Limited
Revenue CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 35%
5 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 41%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 60% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cytocare Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.84 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.35 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cytocare Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cytocare Technologies are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cytocare Technologies Private Limited
Cytocare Technologies has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nedun Chezhian Murugaiyan | Director | 13 Jan 2020 | 6 Years 9 Months | Current |
| Nedunchezhian Vijayalakshmi | Director | 08 Feb 2022 | 4 Years 8 Months | Current |
Peer Comparison of Cytocare Technologies Private Limited
Cytocare Technologies Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Falcon Chemox Private Limited | ₹43.64 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Delhi, India |
| MSL Chemicals Private Limited | ₹43.09 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Narsapur, Telangana, India |
| Brand Scientific Equipment Private Limited | ₹43.04 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Snowbell Machines Private Limited | ₹42.99 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Vasai, Maharashtra, India |
| Gujarat Paraffins Pvt Ltd | ₹42.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mehsana, Gujarat, India |
| Cytocare Technologies Private Limited this company | ₹42.9 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Hyderabad, Telangana, India |
| Kiyana Wellness Private Limited | ₹42.85 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Silverline Medi-Tech Private Limited | ₹42.84 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Ahmedabad, Gujarat, India |
| Ithiel Healthcare Private Limited | ₹42.57 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Ernakulam, Kerala, India |
| Krystalvision Image Systems Private Limited | ₹42.53 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Pune, Maharashtra, India |
| Consolidated Metal Finishing Private Limited | ₹42.49 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Cytocare Technologies by revenue in the Chemicals industry (Industrial Chemicals, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Cytocare Technologies Private Limited
Cytocare Technologies Private Limited is audited by MS AGARWAL & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MS AGARWAL & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cytocare Technologies Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cytocare Technologies Private Limited
Open charges
₹32.56 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Others | ₹32.56 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Cytocare Technologies Private Limited
Employment history and EPFO contributions of people linked to Cytocare Technologies.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cytocare Technologies Private Limited
Cytocare Technologies Private Limited has 8 board changes on record since 2015: 2 appointments and 6 cessations. The latest: Shankar Kaliamoorthy Ponniah ceased to be Director on 12 Feb 2022.
AGM
Cytocare Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cytocare Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 32.56 Lakh with Charge ID 100851753 was registered on 15 Dec 2023.
Ceased
Shankar Kaliamoorthy Ponniah ceased to be Director.
Appointed
Nedunchezhian Vijayalakshmi was appointed as Director.
Appointed
Nedun Chezhian Murugaiyan was appointed as Director.
Ceased
Ramakrishnan Yenuganti ceased to be Additional Director.
Ceased
Jaggaiah Gari Shashidhar ceased to be Director.
Ceased
Venkatakanthaiah Yerramalla ceased to be Director.
Ceased
Adapa Satya Nagamani ceased to be Director.
Ceased
Nedunchezhian Vijayalakshmi ceased to be Director.
Incorporation
22 Oct 2012
Cytocare Technologies Private Limited was registered on 22 Oct 2012 with Roc Hyderabad & aged 13 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Cytocare Technologies Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cytocare Technologies Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cytocare Technologies Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cytocare Technologies Private Limited
Cytocare Technologies has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCC0254Q1ZF | Telangana | Active | 01 Jul 2017 |
| 29AAFCC0254Q1ZA | Karnataka | Active | 23 Mar 2023 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cytocare Technologies Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytocare Technologies Private Limited
Cytocare Technologies is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 October 2012 (14+ years old) and is registered under CIN U72200TG2012PTC083748.
Cytocare Technologies reported revenue of ₹42.9 Cr for FY 2025 (up 60% YoY).
Cytocare Technologies has 2 current directors:
- Nedun Chezhian Murugaiyan - Director
- Nedunchezhian Vijayalakshmi - Director
Cytocare Technologies reported a net profit of ₹3.35 Cr (net margin 7.8%) and EBITDA of ₹4.84 Cr (EBITDA margin 11.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cytocare Technologies is 35% over three years and 48% over five years. In the latest year (FY 2025) revenue rose 60%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cytocare Technologies is 36AAFCC0254Q1ZF, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 29AAFCC0254Q1ZA (Karnataka).
The CIN (Corporate Identification Number) of Cytocare Technologies is U72200TG2012PTC083748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cytocare Technologies was incorporated on 22 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Cytocare Technologies by revenue are Falcon Chemox Private Limited, MSL Chemicals Private Limited, Brand Scientific Equipment Private Limited, Snowbell Machines Private Limited, Gujarat Paraffins Pvt Ltd and 5 more, all in the Chemicals industry (Industrial Chemicals, Medical and Laboratory Equipment).
Shankar Kaliamoorthy Ponniah ceased to be Director on 12 Feb 2022. Nedunchezhian Vijayalakshmi was appointed as Director on 08 Feb 2022. Nedun Chezhian Murugaiyan was appointed as Director on 13 Jan 2020. Cytocare Technologies has 8 board changes on record in total.
Yes, Cytocare Technologies is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0044654).